Defunct Company
Total Trials
7
As Lead Sponsor
1
As Collaborator
6
Total Enrollment
2,222
NCT00314249
Study of Milnacipran for the Treatment of Fibromyalgia
Phase: Phase 3
Role: Collaborator
Start: Apr 30, 2006
Completion: Not specified
NCT00618956
A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring
Start: Oct 31, 2007
NCT01038349
Applications for Methotrexate Optimization in Rheumatoid Arthritis
Phase: N/A
Role: Lead Sponsor
Start: Jun 30, 2009
Completion: Feb 28, 2010
NCT01014585
Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia
Phase: Phase 4
Start: Nov 30, 2009
NCT01077375
Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia
Start: Feb 28, 2010
Completion: Jan 31, 2011
NCT01328002
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Phase: Phase 2
Start: Apr 30, 2011
Completion: Aug 31, 2012
NCT01331109
Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia